ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1
MATERIAL SUITABLE FOR DOWNLOAD
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3.
Low-density lipoprotein cholesterol lowering and coronary plaque regression: Role of non-statin lipid-lowering therapy associated with statins
Walter Masson, Daniel Siniawski
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3.
XIV Annual Scientific Meeting - I International Meeting Sociedad Argentina de Lípidos - International Atherosclerosis Society “Chemistry, biology, genetics: two decades”
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3.
Bioethical aspects related to the genesis and prevention of the atherosclerotic process in childhood Silvina Cuartas, María Pérez Torre
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3.
The digestive component in dyslipidemia of type 2 diabetes mellitus
Cecilia I. Closs, Martin A. Ruiz Diaz, Alberto Cafferata, Juan P. Nogueira
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3.
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
Correlation and concordance between the different lipid markers in primary prevention
Walter Masson, Daniel Siniawski, Patricia Sorroche, Emiliano Rossi
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
Triglycerides and atherosclerosis: review based on the available evidence
Pablo Corral, Macarena Sanchez Pardo
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
Familial hypercholesterolemia. Family screening from an index case
Augusto Lavalle Cobo
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
Meta-analysis of the effect of incretin on the metabolism of intestinal lipoproteins rich in triglycerides (LRT) in type 2 diabetes
Andrea Cartazzo, Juan Patricio Nogueira
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
ASCOT-LLA study: statin-related adverse events, a placebo effect?
Daniel Aymon
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2.
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.
Influence of adiponectin on the accumulation of altered VLDL in atherogenic dyslipidemia
Laura Schreier, Diego Lucero, Verónica Miksztowicz, Carolina Olano, Michelle Bursztyn, Graciela I. López, Valeria Zagoeier, Gabriela Berg.
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.
PCSK9 inhibitors. Your future in the treatment of dyslipidemias
Juan Carlos Rivas
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.
Retinoids and lipid profile. Description of an extreme case
Walter Mason
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.
LEADER study, a lipid approach
Juan Patricio Nogueira
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.
Evaluation of the isolated decrease in HDL cholesterol as an atherogenic risk factor in normal weight pediatric patients
Silvina Cuartas, Maria Perez Torre, Marina Galizzi
ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.